{
  "id": 3327,
  "text": "1273.Zuliani, A.C., et al.Concomitant cisplatin plus radiotherapy and high-dose-rate brachytherapy versus radiotherapy alone for stage IIIB epidermoid cervical cancer: a randomized controlled trial.$J$ Clin Oncol 32, 542-547 (2014).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 1273.Zuliani, A.C., et al.Concomitant cisplatin plus radiotherapy and high-dose-rate brachytherapy versus radiotherapy alone for stage IIIB epidermoid cervical cancer: a randomized controlled trial.$J$ Clin Oncol 32, 542-547 (2014).\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据现有研究和临床证据，对于宫颈癌IIIB期患者，将顺铂化疗与放疗联合使用相比于单纯放疗，联合治疗的效果更佳。具体而言，研究表明，放疗联合顺铂化疗能够显著提高局部肿瘤控制率，同时改善总体生存率。这种联合治疗方式通过化疗增敏作用进一步增强了放疗的效果，从而对疾病的控制更加有效。\n\n因此，对于宫颈癌IIIB期患者，放疗联合顺铂化疗是一种优于单纯放疗的治疗方案，应在临床条件允许的情况下优先考虑。然而，需根据患者的具体情况（如身体状况、耐受性等）制定最适合的个体化治疗方案，并在治疗过程中严格监测患者的反应和可能的毒副作用。",
  "query": "宫颈癌IIIB期患者在治疗过程中，放疗联合顺铂化疗与单纯放疗相比，哪种治疗方式效果更好？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 宫颈癌IIIB期患者在治疗过程中，放疗联合顺铂化疗与单纯放疗相比，哪种治疗方式效果更好？\n\n<reference text>: 1273.Zuliani, A.C., et al.Concomitant cisplatin plus radiotherapy and high-dose-rate brachytherapy versus radiotherapy alone for stage IIIB epidermoid cervical cancer: a randomized controlled trial.$J$ Clin Oncol 32, 542-547 (2014).\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据现有研究和临床证据，对于宫颈癌IIIB期患者，将顺铂化疗与放疗联合使用相比于单纯放疗，联合治疗的效果更佳。具体而言，研究表明，放疗联合顺铂化疗能够显著提高局部肿瘤控制率，同时改善总体生存率。这种联合治疗方式通过化疗增敏作用进一步增强了放疗的效果，从而对疾病的控制更加有效。\n\n因此，对于宫颈癌IIIB期患者，放疗联合顺铂化疗是一种优于单纯放疗的治疗方案，应在临床条件允许的情况下优先考虑。然而，需根据患者的具体情况（如身体状况、耐受性等）制定最适合的个体化治疗方案，并在治疗过程中严格监测患者的反应和可能的毒副作用。"
}